Best Practices for the Development
of PSC-Derived Cellular Therapies

Currently underway, this initiative will provide recommendations to facilitate and streamline the development of PSC-based cellular therapies regardless of regulatory jurisdiction. It will also provide detailed guidance at key product development pain points.

Steering Committee and Working Groups

  • Co-Chair - Kapil Bharti, PhD
    National Institutes of Health, USA​

    Co-Chair - Jacqueline Barry, PhD
    Cell and Gene Therapy Catapult, UK​

    Ricardo Baptista, PhD
    SmartCella, Sweden​

    Melissa Carpenter, PhD
    Carpenter Consulting, USA​

    Derek Hei, PhD
    Kenai Therapeutics, USA​

    Ana Hidalgo-Simon, PhD
    Leiden University Medical Center, Netherlands

    Deborah Hursh, PhD
    Hursh Cell Therapy Consulting, LLC, USA

    Jung-Hyun Kim, PhD
    Ajou University, Korea ​

    Tenneille Ludwig, PhD
    WiCell Research Institute, USA​

    Hideyuki Okano, MD, PhD
    Keio University School of Medicine​

    John Rasko, PhD
    Royal Prince Alfred Hospital, Australia​

    Yoji Sato, PhD
    National Institute of Health Sciences, Japan​

    Glyn Stacey, PhD
    International Stem Cell Banking Initiative, UK​

    Clive Svendsen, PhD
    Cedars Sinai Regenerative Medicine Institute, USA

  • Co-Chair - Kapil Bharti, PhD
    National Institutes of Health, USA

    Co-Chair - Tenneille Ludwig, PhD
    WiCell Research Institute, USA

    Jacqueline Barry, PhD
    Cell and Gene Therapy Catapult, UK​

    Catharina Brandsten, DMsc
    Takara, USA​

    Elizabeth Csaszar, PhD
    Notch Therapeutics, Canada​

    Indumathi Mariappan, PhD
    LV Prasad Eye Institute, India​

    Mark Tomishima, PhD
    Blue Rock Therapeutics, USA​

    Alex Zhang, PhD
    Zephyrm, China​

  • Co-Chair - Jung-Hyun Kim, PhD
    Ajou University, Korea​

    Co-Chair - Glyn Stacey, PhD
    International Stem Cell Banking Initiative, UK​

    Elsa Abranches, PhD
    AstraZeneca, Sweden​

    Ricardo Baptista, PhD
    SmartCella, Sweden​

    Jie Hao, PhD
    National Stem Cell Resource Center, China​

    Hyunyoung Kim, PhD
    KNIH, Korea​

    Tenneille Ludwig, PhD
    WiCell Research Institute, USA​

    Joanne Mountford, PhD
    SNBTS, UK​

  • Co-Chair - Ricardo Baptista, PhD
    SmartCella, Sweden​

    Co-Chair - Uma Lakshmipathy, PhD
    Thermo Fisher, USA​

    Elsa Abranches, PhD
    AstraZeneca, Sweden​

    Kevin Bruce
    Roslin, UK​

    Tamar Harel-Adar, PhD
    MatriCelf, Israel​

    Annaelie Persson, MS
    AstraZeneca, Sweden​

    Anat Shnaiderman, MS
    MatriCelf, Israel​

    Shuyan Wang, PhD
    Zephrym, China​

    Claudia Zylberberg, PhD
    Akron Bio, USA​

  • Co-Chair - Jacqueline Barry, PhD
    Cell and Gene Therapy Catapult, UK​

    Co-Chair - Deborah Hursh, PhD
    Hursh Cell Therapy Consulting, LLC, USA

    Michela Gabaldo, Evotec, MSc
    Italy​

    Ana Hidalgo-Simon, PhD
    Leiden University Medical Center, Netherlands

    Killian Kelly, PhD
    Cynata, Australia​

    John Rasko, PhD
    Royal Prince Alfred Hospital, Australia​

    Yoji Sato, PhD
    National Institute of Health Sciences, Japan

    Somya Viswanathan, PhD
    UHN, Canada

  • Co-Chair -Derek Hei, PhD
    Kenai Therapeutics, USA​

    Co-Chair - Jennifer Hollands, PhD
    Cell Therapies Pty Ltd, Australia​

    Ricardo Baptista, PhD
    SmartCella, Sweden​

    Melissa Carpenter, PhD
    Carpenter Consulting, USA​

    Jennifer Dashnau, PhD
    Century Therapeutics, USA​

    Kate Fynes, PhD
    eXmoor pharma, UK​

    Mashiro Kino-Oka, PhD
    University of Osaka, Japan​

    Dhruv Sareen, PhD
    Cedars-Sinai Medical Center, USA​

  • Co-Chair - Jeanne Loring, PhD
    Aspen Neuroscience, USA​

    Co-Chair - Yoji Sato, PhD
    National Institute of Health Sciences, Japan

    Joy Cavagnaro, PhD
    Access Bio, USA​

    Lila Collins, PhD
    CIRM, USA​

    Shawna Jackman, PhD
    Charles River, USA​

    Christelle Monville, PhD
    I-Stem, France​

    Andras Nagy, PhD
    LTRI, Sinai Health, Canada​

    Clive Svendsen, PhD
    Cedars Sinai, USA​

    Consultant: Michaela Sharpe, PhD
    Moare Solutions, UK​

  • Co-Chair - Claire Henchcliffe, MD, DPhil
    University of California, Irvine, USA​

    Co-Chair - John Rasko, PhD
    Royal Prince Alfred Hospital, Australia​

    Stanley Lazic, MPhil
    Prioris.ai Inc​

    Hideyuki Okano, MD, PhD
    Keio University, Japan​

    Alan Trounson, PhD
    Catherics and Monash University, Australia​

    Graziella Pellegrini, PhD
    University of Modena and Reggio Emilia Modena​

    Somya Viswanathan, PhD
    UHN, Canada​

    Kirsty Wydenbach, MS
    ex-MHRA Consultant, UK​

    Consultant: Roger Barker, PhD
    University of Cambridge, UK​

The ISSCR Standards Initiative is made possible through contributions by:

The ISSCR's Standards for Human Stem Cell Use in Research are strictly copyrighted by the society. No part of this document may be produced in any form without written permission of The International Society for Stem Cell Research. Contact isscr@isscr.org for more information.

©2024 by The International Society for Stem Cell Research. All rights reserved.